Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rethinking smallpox.

Martin M Weiss1, Peter D Weiss, Glenn Mathisen

  • 1Department of Medicine, Veterans Administration, Sepulveda, CA 91343, USA. martin.weiss@med.va.gov

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA.

EClinicalMedicine·2026
Same author

Diagnosis of cystoisosporiasis in a patient with HIV and modestly decreased CD4 counts.

IDCases·2025
Same author

Vertebral osteomyelitis secondary to <i>Streptococcus cristatus</i> infection.

Heliyon·2023
Same author

MRI Ventral Nerve Root Enhancement in Five Patients Presenting With Extremity Weakness Secondary to Neuroinvasive West Nile Virus.

Journal of clinical neuromuscular disease·2016
Same author

HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.

Journal of virology·2016
Same author

A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers.

Neurobehavioral HIV medicine·2015
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Larger Blood Volume Increases Detection of Fastidious Mycobacteria and Fungi in Blood Culture.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Anticalcitonin: Limited utility of a context-dependent biomarker demonstrated in another real-world data set.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Procalcitonin Testing in Community-Acquired Pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Wanted: A Relevant Correlate of Protection for Dengue Vaccines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

A smallpox attack poses significant risks, with aerosolized variola virus transmission potentially underestimated. Pre-event vaccination for first responders and voluntary public programs are recommended, alongside exploring novel defenses.

Area of Science:

  • Biosecurity and Public Health
  • Infectious Disease Epidemiology
  • Bio-defense Strategies

Background:

  • Smallpox (variola virus) remains a significant biothreat, with potential consequences of an attack inadequately addressed by policymakers.
  • The transmission dynamics and infectivity of aerosolized or bioengineered variola virus require thorough examination for effective preparedness.
  • Existing knowledge on morbidity and mortality from mass vaccination is limited, and contagion risks from novel release methods are uncertain.

Purpose of the Study:

  • To analyze the potential impact of a smallpox attack, focusing on aerosolized or bioengineered variola virus.
  • To evaluate arguments for and against pre-event vaccination strategies.
  • To propose and assess potential countermeasures against variola virus, including vaccination and pharmaceutical interventions.

Related Experiment Videos

Main Methods:

  • Review of variola virus transmission and infectivity data.
  • Analysis of potential morbidity and mortality associated with pre-event vaccination.
  • Examination of proposed defenses, including methisazone and N-100 respirators.

Main Results:

  • The extent of contagion from an aerosolized smallpox release may be underestimated.
  • Pre-event vaccination of first responders is urged, with voluntary public programs recommended.
  • Methisazone shows potential for prophylaxis only, not treatment, and its efficacy is uncertain.
  • N-100 respirators may offer protection against transmission for the uninfected public.

Conclusions:

  • Urgent consideration of smallpox attack scenarios and preparedness is necessary.
  • A multi-faceted approach including vaccination, pharmaceutical prophylaxis, and personal protective equipment is crucial.
  • Further research into vaccine-resistant engineered variola virus defenses is warranted.